Login to Your Account



Incentivizing the Less Profitable

PDUFA V Provides Bonuses For Antibiotic Drug Makers

By Brian Orelli
BioWorld Insight Contributing Writer

Monday, June 11, 2012

In addition to the usual details about user fees, the latest reauthorization of the PDUFA package passed by the House and Senate also includes special incentives for antibiotic drugs.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription